|
|
|
| Let Us Handle Your Buffer Preparation | Thermo Fisher Scientific is here to support you with the buffer preparation in your manufacturing workflow. Leaving the non-core activities to us enables you to focus on the patient therapy development. Our capabilities cover off-the-shelf products like WFI, NaOH, NaCl, or EtOH, a library of the most frequently used buffers that are made-to-order, as well as fully customized buffers. |
|
|
FOCUS ON QUALITY/ANALYTICAL METHODS |
|
|
|
By Kishore Hotha, Ph.D., Dr. Hotha’s Life Sciences LLC | Developing a practical chemistry, manufacturing, and controls (CMC) strategy for oligonucleotides and peptides demands a shift in approach in terms of the way you collaborate with your CDMO. |
|
|
|
|
|
| Flow Cytometry Workflow Journey | Poster | BD Biosciences | You have designed your flow cytometry panel for cell manufacturing and patient monitoring. Now what? Use this journey map to help ensure optimal resolution of your populations of interest. |
|
|
|
| The Need For Mass Produced Spheroids | Article | Corning Life Sciences | Researchers looking for reliable ways to recapitulate physiological conditions are turning to spheroids and other 3D objects, seeking ways to mass-produce 3D models for various applications. |
|
|
|
|
QUALITY/ANALYTICAL METHODS SOLUTIONS |
|
|
|
|
|
|
|
By Business Of Biotech | The notion that political influence has no place in biology appears poised for a test it hasn’t studied for. Trump administration nominations, from RFK, Jr. to HHS and Vivek Ramaswamy to the newly-proposed DOGE, are driving speculation over the implications for biotech and other life sciences industries. How should biotech builders be obviating? On the Business of Biotech, we’re joined for some reflection by none other than Allan Shaw. |
|
|
|
|
|
| Measuring Cleanliness | Article | By Michael Moussourakis, Jeff Phillips, Stacy Silverstein, and Malcolm McLaughlin, Alconox Inc. | Learn about methods of detecting and measuring cleanliness in relation to soil quantities. |
|
|
| Welcoming The "Era Of ADCs" | Article | Cytiva | Dr. Loretta Itri sat down to explore the promise of TRODELVY® and other antibody-drug conjugates as transformative treatments for a range of malignancies and intractable diseases. |
|
|
|
|
|
Connect With Bioprocess Online: |
|
|
|